CoChat

Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study

Open access

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index; 1 of the 8 sources its claims cite were checked for support.

Abstract

To the Editor—We read with interest the article by Wang et al [1] describing the clinical features of 69 patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan, China. The authors provide a detailed description of major signs and symptoms of overt disease [2, 3], but fail to give an account of minor symptoms that may be present at earlier stages of the infection. After some patients admitted for coronavirus disease 2019 (COVID-19) at the Infectious Disease Department of L. Sacco Hospital in Milan, Italy, complained of olfactory and taste disorders (OTDs), we performed a cross-sectional survey of the prevalence of these alterations in the context of SARS-CoV-2 infection. On 19 March 2020, a simple questionnaire including questions about the presence or absence of OTDs, their type and time of onset respective to hospitalization were submitted through verbal interview to all SARS-CoV-2–positive hospitalized patients who were able to give informed consent. Of 88 hospitalized patients, 59 were able to be interviewed (29 were nonrespondents, of whom 4 had dementia, 2 had a linguistic barrier, and 23 were on noninvasive ventilation) (Table 1). Of these, 20 (33.9%) reported at least 1 taste or olfactory disorder and 11 (18.6%) both. Twelve patients (20.3%) presented the symptoms before the hospital admission, whereas 8 (13.5%) experienced the symptoms during the hospital stay. Taste alterations were more frequently (91%) before hospitalization, whereas after hospitalization taste and olfactory alteration appeared with equal frequency. Females reported OTDs more frequently than males (10/19 [52.6%] vs 10/40 [25%]; P = .036). Moreover, patients with at least 1 OTD were younger than those without (median, 56 years [interquartile range {IQR}, 47–60] vs 66 [IQR, 52–77]; P = .035). All patients reported the persistence of OTDs at the time of the interview. Characteristics of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Assessed for Taste and Olfactory Disorders (N = 59) Data are presented as no. (%) unless otherwise indicated. Abbreviations: IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. Characteristics of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Assessed for Taste and Olfactory Disorders (N = 59) Data are presented as no. (%) unless otherwise indicated. Abbreviations: IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. Olfactory and taste disorders are well known to be related with a wide range of viral infections [4, 5]. SARS-CoV has demonstrated in a mice model a transneural penetration through the olfactory bulb [6]. Moreover, angiotensin-converting enzyme 2 receptor, which is used by SARS-CoV-2 to bind and penetrate into the cell, is widely expressed on the epithelial cells of the mucosa of the oral cavity [7]. These findings could explain the underlying pathogenetic mechanism of taste and olfactory disorders in SARS-CoV-2 infection. Due to limitations related to the diffusivity of the disease and emergency contingencies, it was impossible to perform a more structured questionnaire associated with validated tests (ie, Pennsylvania smell identification test) [8]. However, our survey shows that OTDs are fairly frequent in patients with SARS-CoV-2 infection and may precede the onset of full-blown clinical disease. In a pandemic context, further investigations on nonhospitalized infected patients are required to ascertain if these symptoms, albeit unspecific, may represent a clinical screening tool to orientate testing of pauci-symptomatic individuals. Acknowledgments. The authors thank all patients enrolled in the cohort and all medical staff (paramedics, nurses, and physicians) who began this fight on one side of the wall and eventually fell ill during the battle. The authors also thank Tiziana Formenti and Bianca Ghisi for their excellent and indefatigable technical help. Potential conflicts of interest. A. G. has received consultancy fees from Mylan and nonfinancial support from Gilead. S. R. and C. G. have received grants and fees for speaker’s bureaus, advisory boards, and continuing medical education (CME) activities from Bristol-Myers Squibb (BMS), ViiV, Merck Sharp & Dohme (MSD), AbbVie, Gilead, and Janssen. M. G. and G. R. have received grants and fees for speaker’s bureaus, advisory boards, and CME activities from BMS, ViiV, MSD, AbbVie, Gilead, Janssen, and Roche. S. A. has received support for research activities from Pfizer and MSD. All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Overview

CoChat Summary

TL;DR

In a cross-sectional survey of 59 hospitalized SARS-CoV-2-positive patients in Milan, 20 (33.9%) reported at least one olfactory or taste disorder, and 11 (18.6%) reported both. The authors conclude these symptoms were fairly frequent and could precede full-blown disease, but they were assessed with a simple self-report questionnaire rather than validated smell/taste tests.

Key findings

  • Of 88 hospitalized patients, 59 were interviewed; among them, 20 (33.9%) reported at least 1 taste or olfactory disorder, and 11 (18.6%) reported both.
  • Twelve patients (20.3%) reported symptoms before hospital admission, while 8 (13.5%) experienced them during the hospital stay; taste alterations were more frequent before hospitalization (91%), whereas after hospitalization taste and olfactory alterations appeared with equal frequency.
  • Patients with at least 1 olfactory/taste disorder were younger than those without: median 56 years (IQR 47–60) vs 66 years (IQR 52–77), P = .035.
  • Females reported OTDs more frequently than males (10/19 [52.6%] vs 10/40 [25%], P = .036). All patients reported persistence of OTDs at the time of interview.

Methods

  • Cross-sectional survey conducted on 19 March 2020 at the Infectious Disease Department of L. Sacco Hospital in Milan, Italy.
  • Participants were 59 SARS-CoV-2-positive hospitalized patients who were able to give informed consent, out of 88 hospitalized patients total.
  • A simple verbal questionnaire assessed presence/absence of olfactory and taste disorders, symptom type, and timing relative to hospitalization; results were summarized descriptively with reported P values for comparisons.

Limitations

  • The paper explicitly states that, due to disease diffusivity and emergency contingencies, it was impossible to use a more structured questionnaire with validated tests such as the Pennsylvania smell identification test.
  • The sample was limited to hospitalized, interviewable patients; 29 of 88 hospitalized patients were nonrespondents, including 4 with dementia, 2 with a linguistic barrier, and 23 on noninvasive ventilation.
  • Evident from the text: the study is cross-sectional and self-reported, so it cannot establish causality or objective measurement of olfactory/taste dysfunction.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/cid/ciaa330

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

1 Valid · 1 Not valid · 4 Not checked · 9 Own results and interpretations

2 more claims

Create a free account to see all 15 claims and to verify the 7 references still open.

See all claims — free account
  • Probably not a substantial claim. 5
  • It may state two separate claims as one. 4

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 13 references

Cited by

See all 1,326

Metadata

Authors
Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., Rusconi, S., Gervasoni, C., Ridolfo, A. L., Rizzardini, G., Antinori, S., & Galli, M.
Affiliations
  • University of Milan (IT)
  • III Infectious Diseases Unit, Azienda Socio-Sanitaria Territoriale-Fatebenefratelli-Sacco, Milan, Italy
  • University of the Witwatersrand (ZA)
Corresponding author
Giacomelli, Andrea
Venue
Clinical Infectious Diseases
Published
2020-03-26
Volume
71
Issue
15
Pages
889-890
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W3013488343
Cited by
1,326
References
12
Citations by year
2026: 7 · 2025: 18 · 2024: 47 · 2023: 121 · 2022: 188 · 2021: 403 · 2020: 540
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
Topics
  • Life Sciences › Neuroscience › Sensory Systems › Olfactory and Sensory Function Studies
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Dermatology › Dermatological and COVID-19 studies
Keywords
COVID-19 pandemic, SARS-CoV-2, olfactory dysfunction, taste disorders, anosmia, ageusia, prevalence, hospitalized patients, symptom onset, sex differences, age differences, persistent symptoms, minor symptoms, Milan, Wuhan
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, China, Cross-Sectional Studies, Humans, Pneumonia, Viral, Taste Disorders, Coronavirus, Coronavirus Infections, Self Report, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. https://app.cochat.ai/papers/10.1093/cid/ciaa330
The paper
Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., Rusconi, S., Gervasoni, C., Ridolfo, A. L., Rizzardini, G., Antinori, S., & Galli, M. (2020). Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaa330

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.